Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders

Published:2022-09 Issue: Volume:183 Page:106362
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Roskoski Robert

Publisher

Elsevier BV

Subject

Pharmacology

Reference118 articles.

1. Dissecting specificity in the Janus kinases: the structures of JAK-specific inhibitors complexed to the JAK1 and JAK2 protein tyrosine kinase domains;Williams;J. Mol. Biol.,2009

2. The JAK kinases: not just another kinase drug discovery target;Wilks;Semin Cell Dev. Biol.,2008

3. Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes;Kawamura;Proc. Natl. Acad. Sci. USA,1994

4. The protein kinase complement of the human genome;Manning;Science,2002

5. The JAK/STAT signaling pathway: from bench to clinic;Hu;Signal Transduct. Target Ther.,2021

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From pre-clinical efficacy to promising clinical trials that delay Type 1 diabetes;Pharmacological Research;2024-10

2. Tetrastigma hemsleyanum polysaccharide ameliorated ulcerative colitis by remodeling intestinal mucosal barrier function via regulating the SOCS1/JAK2/STAT3 pathway;International Immunopharmacology;2024-08

3. Deciphering the therapeutic potential of Myeloid-Specific JAK2 inhibition in acute respiratory distress syndrome;Mucosal Immunology;2024-08

4. An alternative synthetic strategy to construct apixaban analogues;Arkivoc;2024-07-07

5. Clinical pharmacokinetic characteristics of Jaktinib in subjects with hepatic impairment in a phase I trial;Drug Metabolism and Pharmacokinetics;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3